| [1] |
YE Ziqi, ZHOU Yujun, LIU Liu, ZHANG Yanfang, HONG Yun, RAO Yuefeng.
Comprehensive Evaluation of ALK Inhibitors in the First-line Treatment of Patients with ALK-positive Non-small Cell Lung Cancer
[J]. Chinese General Practice, 2026, 29(29): 4258-4264.
|
| [2] |
FENG Shaohui, ZHU Lingyan, SONG Kexin, ZHU Yan, WU Yanling, WU Wenjing, ZHANG Dandan, RAN Limei.
Study on the Relationship between Relevant Indicators in Postmenopausal Women with Subclinical Hypothyroidism and Bone Mineral Density
[J]. Chinese General Practice, 2026, 29(26): 3774-3780.
|
| [3] |
LIN Yanping, HUANG Jiachun, GUO Haiwei, ZHAO Rui, YANG Haolin, WAN Lei, ZHU Genfu, HUANG Hongxing.
Study on the Distribution of TCM Syndrome Types and the Relationship between Muscle-bone-lipid in Patients with Primary Osteoporosis
[J]. Chinese General Practice, 2026, 29(21): 3040-3045.
|
| [4] |
HE Xiaoming, HE Mincong, WEI Tengfei, LIN Tianye, LIU Wengang, ZHANG Qingwen, HE Wei, WEI Qiushi.
Multidimensional Relationship of "TCM Syndrome Type, Clinical Feature and Molecular Typing" in Postmenopausal Patients with Knee Osteoarthritis
[J]. Chinese General Practice, 2026, 29(12): 1588-1598.
|
| [5] |
ZHANG Hanzhi, JIN Hua, MA Le, SHI Ling, CHEN Chen, HUAN Hongmei, YU Dehua.
Analysis of the Quality of Diagnosis and Treatment of Osteoporosis in Shanghai Community Health Service Institutions
[J]. Chinese General Practice, 2026, 29(12): 1548-1557.
|
| [6] |
YANG Yang, GAO Xi.
Research Progress of Paradoxical Bone Formation in Osteoporosis
[J]. Chinese General Practice, 2026, 29(09): 1217-1224.
|
| [7] |
ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali.
Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(29): 3653-3659.
|
| [8] |
XIONG Xin, LI Yang, SHI Feng, YANG Lian, DUAN Wei, CHEN Bei, LI Yong, ZHAO Linwei, FU Quanshui, FAN Xiaoping, YANG Guoqing.
Research on the Measurement System and Calibration of Thoracolumbar Vertebral Density Based on Artificial Intelligence
[J]. Chinese General Practice, 2025, 28(19): 2398-2406.
|
| [9] |
TAN Wenbin, LI Jia, LIU Mingyu, LU Yongxin, CHENG Yaxin.
Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis
[J]. Chinese General Practice, 2025, 28(17): 2092-2100.
|
| [10] |
HE Ting, LI Jia, TAN Wenbin.
Research Progress of Circulatory System Diseases and Secondary Osteoporosis
[J]. Chinese General Practice, 2025, 28(17): 2101-2112.
|
| [11] |
CHEN Beibei, LI Jia, TAN Wenbin.
Progress in the Research of Endocrine and Metabolic System Diseases and Secondary Osteoporosis
[J]. Chinese General Practice, 2025, 28(17): 2082-2091.
|
| [12] |
LI Jia, TAN Wenbin.
The Dilemma of Prevention and Treatment of Secondary Osteoporosis and Its Countermeasures
[J]. Chinese General Practice, 2025, 28(17): 2075-2081.
|
| [13] |
SUN Qing, WU Yuxiao, CUI Limin.
The Prevalence of Osteosarcopenia in Chinese Patients with Type 2 Diabetes Mellitus: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(12): 1520-1526.
|
| [14] |
YANG Chaofu, TAN Guoqing, XU Zhanwang.
Research Progress on the Regulation Mechanism of Senescence-associated Secretory Phenotype in Osteoporosis
[J]. Chinese General Practice, 2024, 27(29): 3685-3695.
|
| [15] |
SU Jin, SHOU Juan, GU Wenqin, YI Chuntao, XU Liping, CHENG Lili, DING Hongjuan, ZHOU Peng, WU Yinghua, QIN Jie, XUE Bin, WEI Baichuan, WANG Qian, PENG Yan, CHENG Yimin, YANG Lan, WEI Yangyang, WANG Lei, QI Jinlin, SHAO Ying, CAI Liming.
Cost Effectiveness Analysis of the Prevention and Treatment of Osteoporosis among the Entire Population in Fenglin Community, Shanghai Based on Markov Chain
[J]. Chinese General Practice, 2024, 27(22): 2789-2796.
|